Back
Intellia Therapeutics Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
NTLA
Intellia Therapeutics
Last Price:
$6.78
Seasonality Move:
25.88%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Intellia Therapeutics Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 57.3% based on the past 8 years of stock performance.
-
Intellia Therapeutics has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Intellia Therapeutics Stock Undervalued?The current Intellia Therapeutics [NTLA] share price is $6.77. The Score for NTLA is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 57.3% based on the past 8 years of stock performance.
Intellia Therapeutics Stock Rating
Sell
6
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics overpriced?
-
Intellia Therapeutics has risen higher in 2 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Intellia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.18
52-Week Low:
5.90
Prediction Charts
Market Cap:
700.8M
Price in USD:
6.77
Volume:
3.1M
Beta:
2.10
Technical Analysis
SMA50:
9.30
SMA100:
11.08
SMA200:
16.29
52-Wk Change:
-72.87%
Stock Predictions
-
Is Intellia Therapeutics stock public?Yes, Intellia Therapeutics is a publicly traded company.
-
What is the Intellia Therapeutics stock quote today?The Intellia Therapeutics stock price is 6.77 USD today.
-
How to buy Intellia Therapeutics stock online?You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 9.21 | 9.31 | 9.38 | 9.09 |
| Mar-25 | 9.32 | 8.73 | 9.36 | 8.59 |
| Mar-26 | 8.65 | 8.31 | 8.82 | 8.12 |
| Mar-27 | 8.15 | 8.40 | 8.43 | 8.11 |
| Mar-28 | 8.27 | 8.07 | 8.43 | 8.03 |
| Mar-31 | 7.69 | 7.11 | 7.83 | 6.98 |
| Apr-1 | 7.08 | 6.66 | 7.14 | 6.59 |
| Apr-2 | 6.50 | 7.30 | 7.59 | 6.50 |
| Apr-3 | 6.87 | 6.89 | 7.21 | 6.77 |
| Apr-4 | 6.83 | 6.63 | 6.91 | 6.43 |
| Apr-7 | 6.19 | 6.54 | 6.88 | 5.90 |
| Apr-8 | 6.87 | 6.28 | 7.03 | 6.12 |
| Apr-9 | 6.10 | 7.08 | 7.38 | 5.97 |
| Apr-10 | 6.79 | 6.77 | 6.91 | 6.37 |
Intellia Therapeutics Earnings
Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics Forecast Revenue Growth
Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.49 per share, and an increase next year of $0.27 per share.
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.